We also focused on analyzing the protein profiles, antioxidant capacity based on 2,2-diphenyl-1-picrylhydrazyl (DPPH) and nitric oxide (NO) scavenging capacity, and the biochemical inhibition of enzymes, such as DPP-IV, and AG, which are relevant to T2D management. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.